HILBREMTI
Live / Registered — Registered (as of 04 Nov 2025)
What this means for you
Registered since 04 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99104388
- Registration number
- 8013672
- Mark type
- Stylized text
- Filed
- 26 Mar 2025
- Published for opposition
- 16 Sept 2025
- Registered
- 04 Nov 2025
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 04 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Aug 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 08 Aug 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 08 Aug 2025 — LETTER OF SUSPENSION E-MAILED
- 08 Aug 2025 — SUSPENSION LETTER WRITTEN
- 07 Aug 2025 — ASSIGNED TO EXAMINER
- 26 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED